Antiphospholipid antibody ELISAs: Survey on the performance of clinical laboratories assessed by using lyophilized affinity-purified IgG with anticardiolipin and anti-β2-Glycoprotein I activity

Thrombosis Research

Volumn 120, Issue 1, 2007, Pages 127-133

  Pengo, Vittorio ^a   Biasiolo, Alessandra ^a   Bison, Elisa ^a   Chantarangkul, Veena ^b   Tripodi, Armando ^b  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ANALYTIC METHOD; ARTICLE; BLOOD CLOTTING TEST; CLINICAL ARTICLE; CLINICAL LABORATORY; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION COEFFICIENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FREEZE DRYING; HUMAN; HUMAN TISSUE; PLASMA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; ENZYME-LINKED IMMUNOSORBENT ASSAY; FREEZE DRYING; HUMANS; IMMUNOGLOBULIN G; LUPUS COAGULATION INHIBITOR; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 34247336928     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2006.07.014     Document Type: Article

References (25)

1. Loizou S., McCrea J.D., Reynolds R., Boyle C.C., and Harris E.N. Measurement of anticardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of the results. Clin Exp Immunol 62 (1985) 738-745
2. 2-Glycoprotein I (apolipoprotein H). Proc Natl Acad Sci 87 (1990) 4120-4124
3. Galli M., Comfurius P., Massen C., Hemker H.C., De Baets M.H., Van Brieda-Vriesman P.J.C., et al. Anticardiolipin antibodies (ACA) are directed not to cardiolipin but to a plasma protein cofactor. Lancet 335 (1990) 1544-1547
4. 2-glycoprotein I as an antigen. J Immunol Methods 143 (1991) 223-229
5. Arvieux J., Darnige L., Caron C., Reber G., Bensa J.C., and Colomb M.G. Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulant. Thromb Haemost 74 (1995) 1120-1125
6. Wilson W.A., Gharavi A.E., Koike T., Lockshin M.D., Branch D.W., Piette J.C., et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum 42 (1999) 1309-1311
7. Miyakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4 (2006) 295-306
8. 2-Glycoprotein I measurement. Thromb Haemost 88 (2002) 66-73
9. Tincani A., Allegri F., Sanmarco M., Cinquini M., Taglietti M., Balestrieri G., et al. Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations. Thromb Haemost 86 (2001) 575-583
10. Tripodi A., Biasiolo A., Chantarangkul V., and Pengo V. Lupus anticoagulant (LA) testing: performance of clinical laboratories assessed by a national survey using lyophilized affinity-purified immunoglobulin with LA activity. Clin Chem 49 10 (2003) 1608-1614
11. 2-glycoprotein I is bound to a suitable surface. Thromb Haemost 73 (1995) 29-34
12. Horbach D.A., van Oort E., Donders R.C., Derksen R.H., and de Groot P.G. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies. Thromb Haemost 76 (1996) 916-924
13. Galli M., Luciani D., Bertolini G., and Barbui T. Lupus anticoagulant are stronger risk factors than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 101 (2003) 1827-1832
14. de Laat H.B., Derksen R.H., Urbanus R.T., Roest M., and De Groot P.G. {Beta}2-glycoprotein I dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome. Blood 104 (2004) 3598-3602
15. de Laat B., Derksen R.H., Urbanus R.T., and de Groot P.G. IgG antibodies that recognize epitope Gly40-Arg43 in domain I of {beta}2-glycoprotein I cause LAC and their presence correlates strongly with thrombosis. Blood 105 (2005) 1540-1545
16. 2-Glycoprotein I, antiprothrombin, and the risk of thrombosis in the antiphospholipid syndrome. Blood 102 (2003) 2717-2723
17. 2-Glycoprotein-I antibodies detection and association with thrombosis. Br J Haematol 89 (1995) 397-402
18. 2-Glycoprotein-I and a conventional cardiolipin immunoassay. Arthritis Rheum 39 (1996) 1606-1607
19. 2-glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am J Med 93 (1992) 181-186
20. 2-Glycoprotein-I in patients with antiphospholipid syndrome. Br J Rhematol 35 (1996) 1239-1243
21. Pengo V., Biasiolo A., Pegoraro C., Cucchini U., Noventa F., and Iliceto S. Antibody profiles for the diagnosis of antiphospholipid syndrome. Thromb Haemost 93 (2005) 1147-1152
22. Tincani A., Allegri F., Balestrieri G., Reber G., Sanmarco M., Meroni P., et al. Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies. Thromb Res 114 (2004) 553-558
23. 2glycoprotein I antibodies. Standardization group of the European Forum on Antiphospholipid Antibodies. J Thromb Haemost 2 (2004) 1860-1862
24. Pengo V., Balestrieri G., Tincani A., Spatola L., Biasiolo A., and Brocco T. Utilization of dilute Russell's viper venom time to detect autoantibodies against beta 2-glycoprotein I which express anticoagulant activity in the presence but not in the absence of exogenous phospholipids. Thromb Haemost 77 1 (Jan 1997) 123-126
25. Pengo V., Biasiolo A., Rampazzo P., and Brocco T. dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti-beta2-glycoprotein I autoantibodies. Thromb Haemost 81 2 (Feb 1999) 256-258